The MHRA formally consults organisations representing public and professional interests, trade associations and industry on proposed statutory changes and other matters of importance regarding medicines through our MLXs.
At the end of the exercise copies of all non-confidential replies can be requested from our Information Centre, email info@mhra.gsi.gov.uk.
Latest MLXs
-
11 Jan 2012 | Public consultation (MLX375): Consolidation and review of UK medicines legislation. Reminder - closes 17 January 2012
Consultation MLX 375 seeks your views on the draft consolidated medicines regulations. Reminder - closes 17 January 2012.
-
21 Dec 2011 | Public consultation (MLX 363): Fees legislation for 2012
This consultation seeks your views on proposals to change the levels of fees charged by the MHRA for the regulation of medicines, including herbal and homoeopathic medicines, and blood establishments and blood banks.
-
06 Dec 2011 | Public Consultation (MLX 374): Transposition of Pharmacovigilance Directive 2010/84/EU
Consultation MLX374 seeks your views on the draft regulations transposing the EU Directive 2010/84/EU on Pharmacovigilance. This Directive must be transposed to UK law by 21 July 2012. This is accompanied by EU Regulation 1235/2010/EU on Pharmacovigilance, to be transposed by 2 July 2012. Comments are invited by 28 February 2012.
-
09 Mar 2011 | Public consultation (MLX 364): The regulation of nicotine containing products (NCPs)
This consultation sought your views on whether to bring all nicotine containing products (NCPs) – with the exception of tobacco and tobacco products - within the medicines licensing regime. This would require all currently unlicensed NCPs on the market, such as electronic cigarettes containing nicotine and nicotine gels, to apply to the MHRA for a medicines marketing authorisation (MA).
-
01 Nov 2010 | Public consultation (MLX 372): Proposals for amendments to the range of medicines available to podiatrists; and to revoke the exemption from licensing requirements for unlicensed herbal remedies
This consultation sought your views on proposals for amendments to the range of medicines which can be sold, supplied or administered by podiatrists; and to revoke the exemption from licensing requirements for unlicensed herbal remedies supplied under section 12(2) of the Medicines Act 1968.
-
25 Aug 2010 | Public consultation (MLX 370): Intention to further amend the Medicines for Human Use (Prescribing by EEA Practitioners) Regulations 2008 (SI 2008/1692)
This consultation sought views on how current guidance can be expanded to provide additional support for community pharmacists following forthcoming legislative changes to the Medicines For Human Use (Prescribing By EEA Practitioners) Regulations 2008 (2008 Regulations).
-
23 Aug 2010 | Public consultation (MLX 371): Proposals to amend medicines legislation to allow student midwives access to the parenteral medicines which can be administered by registered midwives
MLX 371 sought your views on proposals to allow student midwives access to the parenteral medicines which can currently be administered by registered midwives under an exemption in medicines legislation.
-
09 Feb 2010 | Public consultation (MLX 367): Proposals for amendments to the Prescription Only Medicines (Human Use) Order 1997 (the POM Order)
This consultation seeks views on whether to amend the list of Prescription Only Medicines which can be administered parenterally by anyone for the purpose of saving life in an emergency under Article 7 of the POM Order.
-
01 Feb 2010 | Public consultation (MLX 366): Intention to amend the Medicines for Human Use (Prescribing by EEA Practitioners) Regulations 2008 (SI 2008/1692)
MLX 366 sought views on how current professional guidance can be expanded to provide additional support for community pharmacists following forthcoming legislative changes and also seeks views on any impact on businesses or equality issues.
-
18 Dec 2009 | Public consultation (MLX 365): Measures to strengthen the medicines’ supply chain and reduce the risk from counterfeit medicines
MLX 365 seeks your views on specific proposals designed to strengthen the medicines supply chain in the UK. It follows and builds on responses to ideas set out in an earlier consultation.
